Novel Chemotherapeutic Strategies in the Management of Primary Amoebic Meningoencephalitis Due to Naegleria fowleri
- 24 January 2014
- journal article
- Published by Wiley in CNS Neuroscience & Therapeutics
- Vol. 20 (3), 289-290
- https://doi.org/10.1111/cns.12225
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- In Vitro Efficacies of Clinically Available Drugs against Growth and Viability of an Acanthamoeba castellanii Keratitis Isolate Belonging to the T4 GenotypeAntimicrobial Agents and Chemotherapy, 2013
- The immune response toNaegleria fowleriamebae and pathogenesis of infectionFEMS Immunology & Medical Microbiology, 2007
- Pathogenic and opportunistic free-living amoebae:Acanthamoebaspp.,Balamuthia mandrillaris,Naegleria fowleri, andSappinia diploideaFEMS Immunology & Medical Microbiology, 2007
- In‐Vitro Activity of Miltefosine and Voriconazole on Clinical Isolates of Free‐Living Amebas: Balamuthia mandrillaris, Acanthamoeba spp., and Naegleria fowleriThe Journal of Eukaryotic Microbiology, 2006
- Successful Treatment of Naegleria fowleri Meningoencephalitis by Using Intravenous Amphotericin B, Fluconazole and RifampicinArchives of Medical Research, 2005
- The identification of Naegleria fowleri from water and soil samples by nested PCRZeitschrift für Parasitenkunde, 2004
- Successful Treatment of Primary Amebic MeningoencephalitisThe New England Journal of Medicine, 1982
- Amphotericin B Pharmacokinetics in HumansAntimicrobial Agents and Chemotherapy, 1978